Accepted Paper:

Mending and bending antimalarial drug innovation at times of emerging multi-drug resistance in Southeast Asia  
Birgit Ruth Buergi (University of Cambridge)

Paper short abstract:

See below.

Paper long abstract:

First signs of artemisinin resistance in P. falciparum malaria along the Cambodia-Thailand border threaten the vision of a malaria-free world. The international malaria community has therefore renewed calls for sustained financial investment in malaria eradication to avert a potential global health disaster. The controversially discussed question of what the world would be with, or without, the introduction of a co-buyer based drug subsidy for antimalarials, brings into perspective its underlying symbolic logic embossed in the logo to be printed on the packaging of artemisinin-based combination therapies that will be channelled through the Affordable Medicines Facility - malaria. Genealogies of health crises have their own theoretical appeal. My ethnographic analysis however, has a different take on the world's cradle of antimalarial drug resistance.

Panel W091
Medicating crisis